Dr. Zoubeidi led an international team that has published their discovery providing mechanistic insights into prostate cancer resistant to powerful hormone therapy, and proposes a potential treatment regime for reversing currently treatment-resistant phenotypes. This work was published online on September 6, 2021 in the high-impact journal Nature Cell Biology , along with a News and Views article focusing on this publication. The team investigated a…
Read More
Eyam Vaccine and Immunotherapeutics (EYAM), a next-generation vaccine biotechnology company, announced today an agreement with Veristat, a scientific-minded, global clinical research organization (CRO), to plan and coordinate clinical trials of their vaccine program against SARS-CoV-2. “This agreement builds a partnership with a global clinical research organization that has conducted COVID-19 trials around the world. Working with Veristat to plan and implement our clinical…
Read More

A Canadian First in CAR-T Cell Treatment for Adult Leukemia and Lymphoma

A study co-led by Dr. Kevin Hay from Vancouver Coastal Health Research Institute (VCHRI) and Dr. Natasha Kekre at The Ottawa Hospital is investigating the use of specialized chimeric antigen receptor T (CAR-T) cells to treat CD19 positive (CD19+) acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). This first-of-its-kind clinical trial in Canada involves manufacturing and administering a CLIC-1901 cell therapy, which…
Read More
Huntington disease is an inherited neurodegenerative disorder that affects 1 in 7,500 individuals in the Western world. It is characterized by involuntary movements, cognitive disorders including dementia, eventually leading to death. The cause of Huntington disease is a mutation in the HTT gene, which produces the toxic mutant huntingtin protein. One of the strategies presented in this publication, consists of modulating the level of a post-transcriptional modification of mutant huntingtin, called palmitoylation (the addition of a palmitic acid onto a protein).
Read More
Congratulations to DMCBH members Drs. Shannon Kolind and Tamara Vanderwal, who have both been awarded grants in Brain Canada’s 2020 Future Leaders in Canadian Brain Research Program. Backed by the Azrieli Foundation, the Arrell Family Foundation and the Alvin Segal Family Foundation, Brain Canada’s Future Leaders in Canadian Brain Research Program awards 20 grants to up-and-coming researchers to fund game-changing ideas and…
Read More
Bloom Burton & Co. is pleased to announce the three finalists for the 2021 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada’s innovative healthcare industry in the previous year.     The three finalists are, in alphabetical order:     Daniel Durocher,…
Read More
The Mizumoto lab studies the fundamental mechanisms of how our brain develops. In particular, they focus on the specific cellular interface called synapses that the nerve cells use to send and receive information. The number and position of synapses are tightly controlled because it is essential for our brains to function properly. To uncover the genetic and molecular mechanisms underlying precise control of synapse number and position, they use non-parasitic nematode (C. elegans) as an experimental model.
Read More
Dr. Jen Nguyen, a postdoctoral fellow (Microbiology & Biomedical Engineering) in the Tropini Lab, has received a  prestigious NSF fellowship in Biology. Her proposal, “Bacterial spatial organization as a microscale mechanism of ecosystem resilience” received approval within the NSF’s Integrative Research Investigating the Rules of Life Governing Interactions Between Genomes, Environment and Phenotypes theme. The project will explore how the…
Read More
STEMCELL Technologies announces the launch of human pluripotent stem cell (hPSC) characterization and banking services in partnership with WiCell®. These services, offered through STEMCELL’s Contract Assay Services division, will provide researchers with comprehensive cell quality assessments and enable them to generate cell banks using standardized practices. Ultimately, this will reduce variability and improve reproducibility for various downstream applications, including disease modeling, drug discovery, toxicology…
Read More
Ever wondered how you can make artwork with biological reagents found in the lab? How about exploring the latest bleeding-edge research in science and medicine? If these topics interest you, then you won’t want to miss out on this event recap of CBR-SBME Research Day 2021! The Centre for Blood Research (CBR) and School of Biomedical Engineering (SBME) communities gathered online for CBR-SBME Research Day on…
Read More